Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | VDR | P11473 | 8/20 | 0.47 |
| ▸ | AR | P10275 | 8/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14301113 | 0.85 | ALOX15 (0.53) | NPSR1 | |
| SCHEMBL12677545 | 0.82 | NPSR1 (0.68) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL16174405 | 0.82 | CYP1A2 (0.66) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL27004798 | 0.82 | CYP1A2 (0.53) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL12677544 | 0.82 | NPSR1 (0.68) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL1755475 | 0.82 | CYP1A2 (0.53) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL15801282 | 0.82 | CYP1A2 (0.66) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL12180774 | 0.82 | CYP1A2 (0.66) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL8288364 | 0.82 | NPSR1 (0.68) | CYP1A2KDM4EAGTR1LMNAVDR | |
| SCHEMBL11497507 | 0.81 | CYP1A2 (0.65) | CYP1A2KDM4EAGTR1LMNAVDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013067248-A1 | BENZOXAZINES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-05-10 | — | — | WO | disclosed |